Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Germany
/
Healthcare
/
Fresenius Medical Care
Create a narrative
Fresenius Medical Care Community
XTRA:FME Community
3
Narratives
written by author
0
Comments
on narratives written by author
25
Fair Values set
on narratives written by author
Community Investing Ideas
Fresenius Medical Care
Popular
Undervalued
Overvalued
Fresenius Medical Care
AN
AnalystHighTarget
Consensus Narrative from 17 Analysts
Aging, Diabetes, And Digital Health Will Fortify Home Dialysis Care
Key Takeaways Accelerated operational improvements and rapid adoption of new technologies are driving faster-than-expected margin expansion and revenue growth across key segments. Favorable demographic trends, expansion in value-based care, and digital health innovation position the company for sustained, compounding market and earnings growth.
View narrative
€64.88
FV
32.7% undervalued
intrinsic discount
4.90%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
5 days ago
author updated this narrative
Fresenius Medical Care
AN
AnalystLowTarget
Consensus Narrative from 17 Analysts
The Shift To Home Dialysis Will Erode Core Revenues
Key Takeaways Shifting market dynamics and emerging therapies threaten the company's reliance on traditional in-center dialysis, risking long-term revenue stability and growth. Regulatory, reimbursement, and quality pressures are expected to compress margins and increase compliance costs, further weighing on the company's profitability.
View narrative
€40.00
FV
9.1% overvalued
intrinsic discount
2.18%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
17 days ago
author updated this narrative
Fresenius Medical Care
AN
AnalystConsensusTarget
Consensus Narrative from 17 Analysts
Aging Demographics And Home Dialysis Solutions Will Transform Care Delivery
Key Takeaways Global demographic trends and improved patient intake processes are set to drive significant long-term growth in patient volumes and revenues. Technology adoption, operational efficiencies, and value-based care expansion are expected to boost margins and provide more stable, visible earnings.
View narrative
€50.59
FV
13.7% undervalued
intrinsic discount
3.58%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
FME
FME
Fresenius Medical Care
Your Fair Value
€
Current Price
€43.64
5.0% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
24b
2015
2018
2021
2024
2025
2027
2030
Revenue €23.7b
Earnings €796.6m
Advanced
Set Fair Value